SMARCA4 Loss Promotes Late-Stage Tumor Progression in Nonneuroendocrine Small Cell Lung Cancer
This study underscores the importance of tumor context and timing in understanding and targeting SMARCA4 and other chromatin regulators in SCLC.
Authors
- Anthony N. Karnezis (ORCID: https://orcid.org/0000-0003-2924-1126)
- Michael S. Kareta (ORCID: https://orcid.org/0000-0002-6980-9065)
- Godfrey Dzhivhuho (ORCID: https://orcid.org/0000-0001-5795-4049)
- Kyung-Pil Ko (ORCID: https://orcid.org/0000-0002-9554-5972)
- Nicole Kirk (ORCID: https://orcid.org/0000-0002-3609-5502)
- Young Ho Ban (ORCID: https://orcid.org/0000-0002-1936-204X)
- A. Thomas
- Jin Ng
- Kate-Lin Ly
- Jinho Jang
- Miae Choi
- Jae-ll Park
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- The University of Melbourne (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Sanford Research (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- University of Virginia (US)
- University of California, Davis (US)
Publication Details
- Journal
- Molecular Cancer Research
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1158/1541-7786.mcr-25-0592
- Primary Topic
- Chromatin Remodeling and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00